249
Views
1
CrossRef citations to date
0
Altmetric
Original Investigations

Genome-wide DNA methylation analysis in families with multiple individuals diagnosed with schizophrenia and intellectual disability

, , , , , , , , , , , & show all
Pages 741-753 | Received 27 Dec 2022, Accepted 30 Mar 2023, Published online: 18 Apr 2023

References

  • Aberg KA, McClay JL, Nerella S, Clark S, Kumar G, Chen W, Khachane AN, Xie L, Hudson A, Gao G, et al. 2014. Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry. 71(3):255–264.
  • Adalsteinsson BT, Gudnason H, Aspelund T, Harris TB, Launer LJ, Eiriksdottir G, Smith AV, Gudnason V. 2012. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLOS One. 7(10):e46705.
  • Bahado-Singh RO, Vishweswaraiah S, Aydas B, Mishra NK, Yilmaz A, Guda C, Radhakrishna U. 2019. Artificial intelligence analysis of newborn leucocyte epigenomic markers for the prediction of autism. Brain Res. 1724:146457.
  • Bell JT, Spector TD. 2012. DNA methylation studies using twins: what are they telling us? Genome Biol. 13(10):172.
  • Braun PR, Han S, Hing B, Nagahama Y, Gaul LN, Heinzman JT, Grossbach AJ, Close L, Dlouhy BJ, Howard MA III, et al. 2019. Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals. Transl Psychiatry. 9(1):47.
  • Buckley PF. 2019. Neuroinflammation and schizophrenia. Curr Psychiatry Rep. 21(8):72.
  • Cappello S. 2013. Small Rho-GTPases and cortical malformations: fine-tuning the cytoskeleton stability. Small GTPases. 4(1):51–56.
  • Careaga M, Murai T, Bauman MD. 2017. Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates. Biol Psychiatry. 81(5):391–401.
  • Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, McGrath JJ, Whiteford HA. 2018. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull. 44(6):1195–1203.
  • Chen J, Zang Z, Braun U, Schwarz K, Harneit A, Kremer T, Ma R, Schweiger J, Moessnang C, Geiger L, et al. 2020. Association of a reproducible epigenetic risk profile for schizophrenia with brain methylation and function. JAMA Psychiatry. 77(6):628–636.
  • Di Marco B, Bonaccorso CM, Aloisi E, D'Antoni S, Catania MV. 2016. Neuro-inflammatory mechanisms in developmental disorders associated with intellectual disability and autism spectrum disorder: a neuro-immune perspective. CNS Neurol Disord Drug Targets. 15(4):448–463.
  • Do KQ, Cuenod M, Hensch TK. 2015. Targeting oxidative stress and aberrant critical period plasticity in the developmental trajectory to schizophrenia. Schizophr Bull. 41(4):835–846.
  • Du C-P, Tan R, Hou X-Y. 2012. Fyn kinases play a critical role in neuronal apoptosis induced by oxygen and glucose deprivation or amyloid-β peptide treatment. CNS Neurosci Ther. 18(9):754–761.
  • Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suñer D, Cigudosa JC, Urioste M, Benitez J, et al. 2005. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA. 102(30):10604–10609.
  • Gandal MJ, Haney JR, Parikshak NN, Leppa V, Ramaswami G, Hartl C, Schork AJ, Appadurai V, Buil A, Werge TM, et al. 2018. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science. 359(6376):693–697.
  • Govek EE, Newey SE, Van Aelst L. 2005. The role of the rho GTPases in neuronal development. Genes Dev. 19(1):1–49.
  • Guengerich FP. 2020. Cytochrome P450 2E1 and its roles in disease. Chem Biol Interact. 322:109056.
  • Hannon E, Dempster EL, Mansell G, Burrage J, Bass N, Bohlken MM, Corvin A, Curtis CJ, Dempster D, Di Forti M, et al. 2021. DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia. Elife. 10:e58430.
  • He X-B, Yi S-H, Rhee Y-H, Kim H, Han Y-M, Lee S-H, Lee H, Park C-H, Lee Y-S, Richardson E, et al. 2011. Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications. Stem Cells. 29(11):1861–1873.
  • Hilker R, Helenius D, Fagerlund B, Skytthe A, Christensen K, Werge TM, Nordentoft M, Glenthøj B. 2018. Heritability of schizophrenia and schizophrenia spectrum based on the nationwide Danish Twin Register. Biol Psychiatry. 83(6):492–498.
  • Ivashkiv LB, Donlin LT. 2014. Regulation of type I interferon responses. Nat Rev Immunol. 14(1):36–49.
  • Iwase S, Bérubé NG, Zhou Z, Kasri NN, Battaglioli E, Scandaglia M, Barco A. 2017. Epigenetic etiology of intellectual disability. J Neurosci. 37(45):10773–10782.
  • Kebir O, Chaumette B, Krebs M-O. 2018. Epigenetic variability in conversion to psychosis: novel findings from an innovative longitudinal methylomic analysis. Transl Psychiatry. 8(1):93.
  • Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. 2015. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2(3):258–270.
  • Kolarova J, Tangen I, Bens S, Gillessen-Kaesbach G, Gutwein J, Kautza M, Rydzanicz M, Stephani U, Siebert R, Ammerpohl O, et al. 2015. Array-based DNA methylation analysis in individuals with developmental delay/intellectual disability and normal molecular karyotype. Eur J Med Genet. 58(8):419–425.
  • Kular L, Kular S. 2018. Epigenetics applied to psychiatry: clinical opportunities and future challenges. Psychiatry Clin Neurosci. 72(4):195–211.
  • Lévy J, Grotto S, Mignot C, Maruani A, Delahaye-Duriez A, Benzacken B, Keren B, Haye D, Xavier J, Heulin M, et al. 2018. NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder. Clin Genet. 94(2):264–268.
  • Li M, Li Y, Qin H, Tubbs JD, Li M, Qiao C, Lin J, Li Q, Fan F, Gou M, et al. 2021. Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population. Mol Psychiatry. 26(8):4475–4485.
  • Li Z, Chen J, Yu H, He L, Xu Y, Zhang D, Yi Q, Li C, Li X, Shen J, et al. 2017. Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia. Nat Genet. 49(11):1576–1583.
  • Lokmer A, Alladi CG, Troudet R, Bacq-Daian D, Boland-Auge A, Latapie V, Deleuze JF, RajKumar RP, Shewade DG, Bélivier F, et al. 2023. Risperidone response in patients with schizophrenia drives DNA methylation changes in immune and neuronal systems. Epigenomics. 15(1):21–38.
  • Luo C, Pi X, Hu N, Wang X, Xiao Y, Li S, Sweeney JA, Bishop JR, Gong Q, Xie D, et al. 2021. Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function. Mol Psychiatry. 26(11):6926–6936.
  • Matrone C, Petrillo F, Nasso R, Ferretti G. 2020. Fyn tyrosine kinase as harmonizing factor in neuronal functions and dysfunctions. Int J Mol Sci. 21(12):4444.
  • McCartney DL, Walker RM, Morris SW, Anderson SM, Duff BJ, Marioni RE, Millar JK, McCarthy SE, Ryan NM, Lawrie SM, et al. 2018. Altered DNA methylation associated with a translocation linked to major mental illness. NPJ Schizophr. 4(1):5.
  • McCutcheon RA, Reis Marques T, Howes OD. 2020. Schizophrenia–an overview. JAMA Psychiatry. 77(2):201–210.
  • McRae AF, Powell JE, Henders AK, Bowdler L, Hemani G, Shah S, Painter JN, Martin NG, Visscher PM, Montgomery GW. 2014. Contribution of genetic variation to transgenerational inheritance of DNA methylation. Genome Biol. 15(5):R73.
  • Michel M, Schmidt MJ, Mirnics K. 2012. Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol. 72(10):1277–1287.
  • Michels KB, Binder AM. 2018. Considerations for design and analysis of DNA methylation studies. Methods Mol Biol. 1708:31–46.
  • Moran S, Arribas C, Esteller M. 2016. Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics. 8(3):389–399.
  • Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, Beck S. 2014. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. 30(3):428–430.
  • Nordlund J, Bäcklin CL, Wahlberg P, Busche S, Berglund EC, Eloranta M-L, Flaegstad T, Forestier E, Frost B-M, Harila-Saari A, et al. 2013. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 14(9):r105.
  • Owen MJ, O'Donovan MC. 2017. Schizophrenia and the neurodevelopmental continuum: evidence from genomics. World Psychiatry. 16(3):227–235.
  • Owen MJ, O'Donovan MC, Thapar A, Craddock N. 2011. Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry. 198(3):173–175.
  • Parikshak NN, Gandal MJ, Geschwind DH. 2015. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet. 16(8):441–458.
  • Pedraz-Petrozzi B, Elyamany O, Rummel C, Mulert C. 2020. Effects of inflammation on the kynurenine pathway in schizophrenia – a systematic review. J Neuroinflammation. 17(1):56.
  • Peters TJ, Buckley MJ, Statham AL, Pidsley R, Samaras K, V, Lord R, Clark SJ, Molloy PL. 2015. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. 8:6.
  • Planterose Jiménez B, Liu F, Caliebe A, Montiel González D, Bell JT, Kayser M, Vidaki A. 2021. Equivalent DNA methylation variation between monozygotic co-twins and unrelated individuals reveals universal epigenetic inter-individual dissimilarity. Genome Biol. 22(1):18.
  • Pronovost GN, Hsiao EY. 2019. Perinatal interactions between the microbiome, immunity, and neurodevelopment. Immunity. 50(1):18–36.
  • Rees E, Creeth HDJ, Hwu H-G, Chen WJ, Tsuang M, Glatt SJ, Rey R, Kirov G, Walters JTR, Holmans P, et al. 2021. Schizophrenia, autism spectrum disorders and developmental disorders share specific disruptive coding mutations. Nat Commun. 12(1):5353.
  • Reijnders MRF, Ansor NM, Kousi M, Yue WW, Tan PL, Clarkson K, Clayton-Smith J, Corning K, Jones JR, Lam WWK, et al. 2017. RAC1 missense mutations in developmental disorders with diverse phenotypes. Am J Hum Genet. 101(3):466–477.
  • Richetto J, Meyer U. 2021. Epigenetic modifications in schizophrenia and related disorders: molecular scars of environmental exposures and source of phenotypic variability. Biol Psychiatry. 89(3):215–226.
  • Sachse SM, Lievens S, Ribeiro LF, Dascenco D, Masschaele D, Horré K, Misbaer A, Vanderroost N, De Smet AS, Salta E, et al. 2019. Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation. EMBO J. 38(6):e99669.
  • Sahoo T, Theisen A, Rosenfeld JA, Lamb AN, Ravnan JB, Schultz RA, Torchia BS, Neill N, Casci I, Bejjani BA, et al. 2011. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet Med. 13(10):868–880.
  • Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK. 2009. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell. 137(1):47–59.
  • Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach JP, Conneely OM. 1998. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci USA. 95(7):4013–4018.
  • Schenkel LC, Rodenhiser DI, Ainsworth PJ, Paré G, Sadikovic B. 2016. DNA methylation analysis in constitutional disorders: clinical implications of the epigenome. Crit Rev Clin Lab Sci. 53(3):147–165.
  • Shen L, Lv X, Huang H, Li M, Huai C, Wu X, Wu H, Ma J, Chen L, Wang T, et al. 2021. Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese. EBioMedicine. 72:103609.
  • Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 3:3.
  • Sørensen HJ, Mortensen EL, Schiffman J, Reinisch JM, Maeda J, Mednick SA. 2010. Early developmental milestones and risk of schizophrenia: a 45-year follow-up of the Copenhagen perinatal cohort. Schizophr Res. 118(1–3):41–47.
  • Subbanna M, Shivakumar V, Venugopal D, Narayanaswamy JC, Berk M, Varambally S, Venkatasubramanian G, Debnath M. 2020. Impact of antipsychotic medication on IL-6/STAT3 signaling axis in peripheral blood mononuclear cells of drug-naive schizophrenia patients. Psychiatry Clin Neurosci. 74(1):64–69.
  • Susai SR, Föcking M, Mongan D, Heurich M, Coutts F, Egerton A, Whetton T, Winter-van Rossum I, Unwin RD, Pollak TA, et al. 2023. Association of complement and coagulation pathway proteins with treatment response in first-episode psychosis: a longitudinal analysis of the OPTiMiSE clinical trial. Schizophr Bull. sbac201. https://doi.org/10.1093/schbul/sbac201
  • Szczepankiewicz A, Rybakowski JK, Skibinska M, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Wilkosc M, Hauser J. 2009. FYN kinase gene: another glutamatergic gene associated with bipolar disorder? Neuropsychobiology. 59(3):178–183.
  • Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. 2019. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(D1):D607–D613.
  • Takahashi S. 2013. Heterogeneity of schizophrenia: genetic and symptomatic factors. Am J Med Genet B Neuropsychiatr Genet. 162(7):648–652.
  • Tang Y, Li M, Wang J, Pan Y, Wu F-X. 2015. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 127:67–72.
  • Tejada-Simon MV. 2015. Modulation of actin dynamics by Rac1 to target cognitive function. J Neurochem. 133(6):767–779.
  • Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, Beck S. 2013. A beta-mixture quantile normalization method for correcting probe design bias in illumina infinium 450 k DNA methylation data. Bioinformatics. 29(2):189–196.
  • Threadgill R, Bobb K, Ghosh A. 1997. Regulation of dendritic growth and remodeling by rho, rac, and Cdc42. Neuron. 19(3):625–634.
  • Torretta S, Rampino A, Basso M, Pergola G, Di Carlo P, Shin JH, Kleinman JE, Hyde TM, Weinberger DR, Masellis R, et al. 2020. NURR1 and ERR1 modulate the expression of genes of a DRD2 coexpression network enriched for schizophrenia risk. J Neurosci. 40(4):932–941.
  • Vasilyev SA, Skryabin NA, Kashevarova AA, Tolmacheva EN, Savchenko RR, Vasilyeva OY, Lopatkina ME, Zarubin AA, Fishman VS, Belyaeva EO, et al. 2021. Differential DNA methylation of the IMMP2L gene in families with maternally inherited 7q31.1 microdeletions is associated with intellectual disability and developmental delay. Cytogenet Genome Res. 161(3–4):105–119.
  • Vissers LE, Gilissen C, Veltman JA. 2016. Genetic studies in intellectual disability and related disorders. Nat Rev Genet. 17(1):9–18.
  • Walton E, Hass J, Liu J, Roffman JL, Bernardoni F, Roessner V, Kirsch M, Schackert G, Calhoun V, Ehrlich S. 2016. Correspondence of DNA methylation between blood and brain tissue and its application to schizophrenia research. Schizophr Bull. 42(2):406–414.
  • Watkins SH, Ho K, Testa C, Falk L, Soule P, Nguyen LV, FitzGibbon S, Slack C, Chen JT, Davey Smith G, et al. 2022. The impact of low input DNA on the reliability of DNA methylation as measured by the illumina infinium MethylationEPIC BeadChip. Epigenetics. 17(13):2366–2376.
  • Wettenhall JM, Smyth GK. 2004. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 20(18):3705–3706.
  • Wickham H. 2016. ggplot2: elegant graphics for data analysis. New York (NY): Springer-Verlag.
  • Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. 2021. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2(3):100141.
  • Xing G, Zhang L, Russell S, Post R. 2006. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders. Schizophr Res. 84(1):36–56.
  • Yan W, Chen Z-Y, Chen J-Q, Chen H-M. 2016. BMP2 promotes the differentiation of neural stem cells into dopaminergic neurons via miR-145-mediated upregulation of Nurr1 expression. Am J Transl Res. 8(9):3689–3699.
  • Zamboni V, Jones R, Umbach A, Ammoni A, Passafaro M, Hirsch E, Merlo GR. 2018. Rho GTPases in intellectual disability: from genetics to therapeutic opportunities. Int J Mol Sci. 19(6):1821.
  • Zhou W, Laird PW, Shen H. 2017. Comprehensive characterization, annotation and innovative use of infinium DNA methylation BeadChip probes. Nucleic Acids Res. 45(4):e22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.